Taro

Taro is a pharmaceutical company that manufactures and supplies prescription and over-the-counter products for life science and healthcare markets. Read more

Uday Vijaykumar Baldota's photo - CEO of Taro

CEO

Uday Vijaykumar Baldota

CEO Approval Rating

78/100

Founded:

1950

Status:

TARO TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

BMS is Taro's top competitor. BMS is headquartered in New York, New York, and was founded in 1858. BMS is in the Pharmaceuticals field. BMS generates 6,639% the revenue of Taro.

Celgene is seen as one of Taro's top competitors. Celgene's headquarters is in Summit, New Jersey, and was founded in 1986. Celgene competes in the Biotechnology industry. Celgene generates 2,369% of Taro's revenue.

GSK has been one of Taro's top competitors. GSK was founded in 2000, and its headquarters is in Middlesex, England. GSK competes in the Pharmaceuticals field. GSK has 92,659 more employees than Taro.

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is Pfizer a competitor of Taro?

Taro Quarterly and Annual Revenue

Coming soon for Taro!

Annual Revenue

$644.8M

Taro's revenue is the ranked 17th among it's top 10 competitors. The top 10 competitors average 31.1B.

Taro Acquisitions

COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION

-

Aquinox Pharmaceuticals (Canada) Inc

Jul 2020

Source »
$8.2M
-

These are all the companies that Taro has acquired. Taro's latest acquisition was Aquinox Pharmaceuticals (Canada) Inc in Jul 2020.

Taro Funding History

No recent funding data found related to Taro

Taro Investments

No recent investments found related to Taro

These are all the companies that Taro has invested in. Taro's latest investment was Aquinox Pharmaceuticals (Canada) Inc in Jul 2020.

Taro News

January 27, 2021NewsOk

Fiscal 3Q Earnings Snapshot

HAIFA BAY, Israel (AP) _ Taro Pharmaceutical Industries Ltd. (TARO) on Wednesday reported fiscal thir... See more »
January 21, 2021BioSpace

Taro to Announce Third Quarter Results on January 27, 2021

Taro Pharmaceutical Industries Ltd. (NYSE:TARO) announced today that it plans to release its financia... See more »
October 28, 2020MarketScreener

Provides Results for September 30, 2020

(marketscreener.com) Taro Pharmaceutical Industries Ltd. today provided unaudited financial results f... See more »
October 28, 2020St Louis Post Dispatch

Fiscal 2Q Earnings Snapshot

HAIFA BAY, Israel (AP) - Taro Pharmaceutical Industries Ltd. (TARO) on Wednesday reported fiscal seco... See more »
July 29, 2020MarketScreener

Provides Results for Quarter Ended June 30, 2020

(marketscreener.com) Quarter reflects One-Time Charge for Global Resolution with DOJhttps://www.marke... See more »
July 29, 2020St Louis Post Dispatch

Fiscal 1Q Earnings Snapshot

HAIFA BAY, Israel (AP) - Taro Pharmaceutical Industries Ltd. (TARO) on Wednesday reported a fiscal fi... See more »

Taro Press Releases

December 24, 2016Business Wire India

Taro Announces Sale of U.S. Rights to Keveyis® to Strongbridge Biopharma plc

Business Wire IndiaTaro Pharmaceutical Industries Ltd. (NYSE:TARO) ("Taro" or the ...... See more »
December 24, 2016NPR

Taro Announces Sale of U.S. Rights to Keveyis® to Strongbridge Biopharma plc

Business Wire India Taro Pharmaceutical Industries Ltd. (NYSE:TARO) ("Taro" or the "Company") announc... See more »
December 7, 2016Blackbird

Glancy Prongay & Murray Announces the Filing of a Securities Class Action on Behalf of Taro Pharmaceutical Industries Ltd. Investors and Encourages Investors to Contact the Firm

LOS ANGELES-(BUSINESS WIRE)-Glancy Prongay & Murray LLP ("GPM") announces that a class action lawsuit... See more »
June 22, 2016Business Wire India

Taro Announces Resignation of Chief Financial Officer

Business Wire IndiaTaro Pharmaceutical Industries Ltd. (NYSE: TARO) ("Taro" or the "Company") announc... See more »
February 10, 2016PR Newswire

Kamedis and Taro Announce Availability of the Kamedis® Bio-Herbal Dandruff Care System at Walgreens

TEL AVIV, Israel, Feb. 10, 2016 /PRNewswire/ -- Kamedis Inc., a global provider of clinically proven ... See more »

Social Media

Taro Headquarters

3 Skyline Drive Suite 120

Hawthorne, New York10532

866-923-4914

Driving Directions »

Trending Companies

Taro Summary

ABOUT

Overview

Taro is a pharmaceutical company that manufactures and supplies prescription and over-the-counter products for life science and healthcare markets. Taro was founded in 1950. Taro's headquarters is located in Hawthorne, New York, USA 10532. Taro's late...

CEO

Taro's CEO, Uday Vijaykumar Baldota, currently has an approval rating of 78%. Taro's primary competitors are BMS, Celgene & GSK.

Website

taro.com

Frequently Asked Questions about Taro

  1. When was Taro founded?

    Taro was founded in 1950
  2. Who is Taro's CEO?

    Taro's CEO is Uday Vijaykumar Baldota
  3. How much revenue does Taro generate?

    Taro generates $644.8M in revenue
  4. How much funding does Taro have?

    Taro has historically raised $0 in funding
  1. Where is Taro's headquarters?

    Taro's headquarters is in Hawthorne New York, USA
  2. How many employees does Taro have?

    Taro has 1,407 employees
  3. Who are Taro's competitors?

    Taro's top competitors are BMS, Celgene, GSK